EXPLOITING FERROPTOSIS FOR THE TREATMENT OF RB1-DEFICIENT LETHAL PROSTATE CANCER

$469,789FY2022Defense Health AgencyDOD

Duke University, Durham NC

Investigators

EXPLOITING FERROPTOSIS FOR THE TREATMENT OF RB1-DEFICIENT LETHAL PROSTATE CANCER · GrantIndex